Section Arrow
Quote
KNSA.NASDAQ
- Kiniksa Pharmaceuticals International plc
Quotes are at least 15-min delayed:2026/01/16 07:38 EST
Pre Market
Last
 38.19
+0.27 (+0.71%)
Bid
36.43
Ask
40
High 38.45 
Low 37.49 
Volume 22 
Regular Hours (Closed)
Last
 37.92
-1.64 (-4.15%)
Day High 
39.7413 
Prev. Close
39.56 
1-M High
44.4199 
Volume 
1.01M 
Bid
36.43
Ask
40
Day Low
37.02 
Open
39.56 
1-M Low
37.56 
Market Cap 
3.00B 
Currency 美元 
P/E 87.91 
%Yield -- 
10-SMA 41.31 
20-SMA 41.68 
50-SMA 41.13 
52-W High 44.4199 
52-W Low 18.12 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.45/1.50
Enterprise Value
3.01B
Balance Sheet
Book Value Per Share
7.06
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
423.24M
Operating Revenue Per Share
3.28
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SXTCChina SXT Pharmaceuticals Inc.0.1061+0.0098+10.18%-- 
Pre Market 0.0992 -0.0069 -6.50%
PRFXPainReform Ltd0.8191-0.0079-0.96%0.03PE
Pre Market 0.8862 +0.0671 +8.19%
IXHLIncannex Healthcare0.382-0.0067-1.72%-- 
Pre Market 0.388 +0.006 +1.57%
CGCCanopy Growth Corp1.22------ 
Pre Market 1.215 -0.005 -0.41%
HIMSHims & Hers Health31.23-0.09-0.29%58.77PE
Pre Market 31.4 +0.17 +0.54%
Industry overview quotes are at least 15 minutes delayed
Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.